Article ; Online: Prevention of post-operative recurrence of Crohn's disease.
World journal of gastroenterology
2014 Volume 20, Issue 5, Page(s) 1147–1154
Abstract: Endoscopic and clinical recurrence of Crohn's disease (CD) is a common occurrence after surgical resection. Smokers, those with perforating disease, and those with myenteric plexitis are all at higher risk of recurrence. A number of medical therapies ... ...
| Abstract | Endoscopic and clinical recurrence of Crohn's disease (CD) is a common occurrence after surgical resection. Smokers, those with perforating disease, and those with myenteric plexitis are all at higher risk of recurrence. A number of medical therapies have been shown to reduce this risk in clinical trials. Metronidazole, thiopurines and anti-tumour necrosis factors (TNFs) are all effective in reducing the risk of endoscopic or clinical recurrence of CD. Since these are preventative agents, the benefits of prophylaxis need to be weighed-against the risk of adverse events from, and costs of, therapy. Patients who are high risk for post-operative recurrence should be considered for early medical prophylaxis with an anti-TNF. Patients who have few to no risk factors are likely best served by a three-month course of antibiotics followed by tailored therapy based on endoscopy at one year. Clinical recurrence rates are variable, and methods to stratify patients into high and low risk populations combined with prophylaxis tailored to endoscopic recurrence would be an effective strategy in treating these patients. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Anti-Bacterial Agents/economics ; Anti-Bacterial Agents/therapeutic use ; Anti-Inflammatory Agents/economics ; Anti-Inflammatory Agents/therapeutic use ; Cost-Benefit Analysis ; Crohn Disease/diagnosis ; Crohn Disease/economics ; Crohn Disease/surgery ; Digestive System Surgical Procedures/adverse effects ; Digestive System Surgical Procedures/economics ; Drug Costs ; Endoscopy, Gastrointestinal ; Gastrointestinal Agents/economics ; Gastrointestinal Agents/therapeutic use ; Humans ; Patient Selection ; Predictive Value of Tests ; Risk Assessment ; Risk Factors ; Secondary Prevention ; Time Factors ; Treatment Outcome | |||||
| Chemical Substances | Anti-Bacterial Agents ; Anti-Inflammatory Agents ; Gastrointestinal Agents | |||||
| Language | English | |||||
| Publishing date | 2014-01-19 | |||||
| Publishing country | United States | |||||
| Document type | Journal Article ; Research Support, N.I.H., Extramural ; Review | |||||
| ZDB-ID | 2185929-2 | |||||
| ISSN | 2219-2840 ; 1007-9327 | |||||
| ISSN (online) | 2219-2840 | |||||
| ISSN | 1007-9327 | |||||
| DOI | 10.3748/wjg.v20.i5.1147 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 6039: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.